Progress For Africa, As First Internal mAb Biosimilar Trialed In Europe
Proposed Adalimumab Biosimilar Adessia Dosed Last Month In Germany
Executive Summary
The quality of analytical data obtained so far and accepted by the German Federal Ministry of Health’s Paul-Ehrlich Institute has been praised as part of the step forward.